Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia

Thomas C.C. Boerlage, Charlotte L.E. van Hees, Alwin D.R. Huitema, Fanny N. Lauw

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Proton pump inhibitor (PPI)-induced hypomagnesemia is currently a major topic. Patients undergoing Roux-en-Y gastric bypass are generally prescribed PPI prophylaxis after surgery. We investigated the prevalence of hypomagnesemia in our bariatric population. We reviewed the files of 1000 postoperative patients for serum magnesium level during PPI use. We found only five cases of hypomagnesemia, none of which was evidently related to PPI use. We conclude that the risk of hypomagnesemia during 1 year of prophylactic PPI use after Roux-en-Y gastric bypass (RYGB) is minimal and laboratory screening is probably not necessary.

Original languageEnglish
Pages (from-to)688-690
Number of pages3
JournalObesity Surgery
Volume26
Issue number3
DOIs
Publication statusPublished - 1 Mar 2016
Externally publishedYes

Keywords

  • Gastric bypass
  • Hypomagnesemia
  • Proton pump inhibitor

Fingerprint

Dive into the research topics of 'Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia'. Together they form a unique fingerprint.

Cite this